NEO: NGS and MRD growth, community focus, and portfolio innovation drive strong financial outlook
Management outlined a focused strategy on community oncology, leveraging a broad portfolio and tailored solutions to drive growth. NGS and MRD are key revenue drivers, with robust financial performance and margin expansion expected. Investments target sales, R&D, and IT upgrades.Based on NeoGenomic…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.